Next Article in Journal
Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
Next Article in Special Issue
Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients
Previous Article in Journal
Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption
Previous Article in Special Issue
Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
 
 
Review

Article Versions Notes

Pharmaceutics 2019, 11(3), 140; https://doi.org/10.3390/pharmaceutics11030140
Action Date Notes Link
article xml file uploaded 21 March 2019 13:18 CET Original file -
article pdf uploaded. 21 March 2019 13:18 CET Version of Record https://www.mdpi.com/1999-4923/11/3/140/pdf-vor
article xml file uploaded 27 March 2019 11:09 CET Update -
article xml uploaded. 27 March 2019 11:09 CET Update https://www.mdpi.com/1999-4923/11/3/140/xml
article pdf uploaded. 27 March 2019 11:09 CET Updated version of record https://www.mdpi.com/1999-4923/11/3/140/pdf
article html file updated 27 March 2019 11:10 CET Original file -
article html file updated 2 April 2019 04:55 CEST Update -
article html file updated 4 April 2019 17:44 CEST Update -
article html file updated 11 April 2019 18:37 CEST Update -
article html file updated 25 April 2019 23:35 CEST Update -
article html file updated 17 October 2019 00:04 CEST Update -
article html file updated 11 February 2020 23:56 CET Update https://www.mdpi.com/1999-4923/11/3/140/html
Back to TopTop